Holen Sie sich die Stockscreener-App
12.80
6.57%
-0.90
Handel nachbörslich:
12.91
0.11
+0.86%
Schlusskurs vom Vortag:
$13.70
Offen:
$13.71
24-Stunden-Volumen:
4.85M
Relative Volume:
1.68
Marktkapitalisierung:
$955.51M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-13.91
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
-10.80%
1M Leistung:
+3.48%
6M Leistung:
+29.95%
1J Leistung:
+123.00%
1-Tages-Spanne:
$12.76
$13.93
1-Wochen-Bereich:
$12.76
$14.96
52-Wochen-Spanne:
$5.31
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Vergleichen Sie CRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
12.80 | 1.09B | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
Will CorMedix Inc. benefit from AI trendsJuly 2025 Closing Moves & Fast Moving Stock Watchlists - khodrobank.com
Wall Street Analysts Think CorMedix (CRMD) Could Surge 32.04%: Read This Before Placing a Bet - sharewise.com
Using portfolio simulators with CorMedix Inc. included2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Signal strength of CorMedix Inc. stock in tech scannersJuly 2025 Volume & Daily Stock Trend Watchlist - Newser
CorMedix completes $300M acquisition of Melinta Therapeutics - NJBIZ
CorMedix Inc. stock chart pattern explainedMarket Growth Review & Verified Technical Trade Signals - Newser
How high can CorMedix Inc. stock goEarnings Recap Summary & Short-Term Swing Trade Alerts - Newser
Using Bollinger Bands to evaluate CorMedix Inc.Day Trade & Community Consensus Stock Picks - Newser
Sentiment analysis tools applied to CorMedix Inc.2025 Technical Overview & Fast Momentum Stock Entry Tips - Newser
CorMedix Inc. stock momentum explainedJuly 2025 Spike Watch & Low Volatility Stock Recommendations - Newser
Comparing CorMedix Inc. in custom built stock radarsPortfolio Value Report & Consistent Income Trade Recommendations - Newser
Can trapped investors hope for a rebound in CorMedix Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - Newser
Real time pattern detection on CorMedix Inc. stockJuly 2025 Trends & AI Powered Trade Plan Recommendations - Newser
What makes CorMedix Inc. stock price move sharplyWeekly Trend Summary & Smart Money Movement Alerts - Newser
Using RSI to spot recovery in CorMedix Inc.Weekly Market Report & High Yield Stock Recommendations - Newser
What is the long term forecast for CorMedix Inc. stockJuly 2025 Catalysts & Accurate Entry/Exit Alerts - khodrobank.com
Heatmap analysis for CorMedix Inc. and competitorsPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
CorMedix Shares Drop 1.28% as $380M Volume Ranks 291st in Market Activity, $300M Melinta Acquisition Fuels Growth - AInvest
CorMedix Inc. stock volume spike explained2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
CorMedix Completes Acquisition of Melinta Therapeutics - citybiz
What the charts say about CorMedix Inc. todayJuly 2025 Movers & Technical Pattern Based Buy Signals - Newser
How CorMedix Inc. stock performs during market volatility2025 Price Action Summary & Low Drawdown Trading Strategies - Newser
Should you buy the dip on CorMedix Inc.2025 Big Picture & Weekly High Return Stock Opportunities - khodrobank.com
Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path? - sharewise.com
What’s the recovery path for long term holders of CorMedix Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
CorMedix Bets Big On Melinta In $300 Million Deal - Finimize
CorMedix Inc. Announces CFO Changes, Effective August 29, 2025 - MarketScreener
CorMedix Completes Acquisition of Melinta Therapeutics; Updates 2025 Revenue Outlook - MarketScreener
CorMedix appoints new leadership team following Melinta acquisition - TipRanks
Cormedix completes acquisition of Melinta Therapeutics, raises financial guidance and announces new Leadership Team - MarketScreener
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team - The Manila Times
CorMedix Announces Acquisition of Melinta Therapeutics, Expanding Product Portfolio and Projected Revenues - Quiver Quantitative
CorMedix Acquires Melinta Therapeutics, Expands Portfolio and Raises Guidance. - AInvest
$300M Pharma Deal: CorMedix Acquires Melinta's 7-Drug Portfolio, Targets $350M Revenue by 2025 - Stock Titan
Published on: 2025-09-02 05:08:27 - Newser
Published on: 2025-09-02 00:05:49 - Newser
Fed Watch: What is the long term forecast for CorMedix Inc. stockJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Will CorMedix Inc. benefit from current market trends2025 Valuation Update & Daily Profit Maximizing Trade Tips - khodrobank.com
Volume spikes in CorMedix Inc. stock – what they meanJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - Newser
Should I set a stop loss on CorMedix Inc.July 2025 Setups & Free High Return Stock Watch Alerts - خودرو بانک
Applying Elliott Wave Theory to CorMedix Inc.Market Trend Summary & Technical Confirmation Trade Alerts - Newser
Can technical indicators confirm CorMedix Inc.’s reversalWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Order flow analysis tools used on CorMedix Inc.2025 Earnings Impact & Reliable Trade Execution Plans - Newser
Combining price and volume data for CorMedix Inc.2025 Trade Ideas & Weekly Momentum Picks - Newser
CorMedix Inc. stock retracement – recovery analysis2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):